NUZYRA: payments to doctors
Payments that named NUZYRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.2M
- Providers
- 30,007
- Transactions
- 110,686
- Average per transaction
- $74
The per-transaction average — $74 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 30,007 providers the average total is $272, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | $8,163,475 | 100.0% |